Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgensztern

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
The Lancet. Oncology|July 8, 2015
Genomic alterations in lung adenocarcinomaSiddhartha Devarakonda, Daniel Morgensztern, Ramaswamy Govindan
Biologics : Targets & Therapy|June 10, 2010
Management of patients with advanced non-small cell lung cancer: role of gefitinibVamsidhar Velcheti, Daniel Morgensztern, Ramaswamy Govindan
Clinical Lung Cancer|September 15, 2010
Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancerJanakiraman Subramanian, Daniel Morgensztern, Ramaswamy Govindan
Clinical Lung Cancer|May 21, 2013
Molecularly targeted therapies in locally advanced non-small-cell lung cancerSiddhartha Devarakonda, Daniel Morgensztern, Ramaswamy Govindan
Oncology (Williston Park, N.Y.)|November 29, 2013
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinomaSiddhartha Devarakonda, Daniel Morgensztern, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
MET Mutation Associated with Responsiveness to CrizotinibSaiama N Waqar, Daniel Morgensztern, Jennifer Sehn
Journal of Thoracic Disease|September 14, 2016
Role for adjuvant chemotherapy in patients with resected small cell lung cancerLingling Du, Saiama N Waqar, Daniel Morgensztern
Hematology/Oncology Clinics of North America|December 4, 2016
Immunotherapy in Lung CancerLingling Du, Roy S Herbst, Daniel Morgensztern
Annals of Translational Medicine|November 22, 2016
Immune checkpoint inhibition in patients with brain metastasesTanner Johanns, Saiama N Waqar, Daniel Morgensztern
Cancer Treatment and Research|August 19, 2016
Multimodality Therapy for NSCLCLingling Du, Saiama N Waqar, Daniel Morgensztern
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
The Lancet. Oncology|July 8, 2015
Genomic alterations in lung adenocarcinomaSiddhartha Devarakonda, Daniel Morgensztern, Ramaswamy Govindan
Biologics : Targets & Therapy|June 10, 2010
Management of patients with advanced non-small cell lung cancer: role of gefitinibVamsidhar Velcheti, Daniel Morgensztern, Ramaswamy Govindan
Clinical Lung Cancer|September 15, 2010
Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancerJanakiraman Subramanian, Daniel Morgensztern, Ramaswamy Govindan
Clinical Lung Cancer|May 21, 2013
Molecularly targeted therapies in locally advanced non-small-cell lung cancerSiddhartha Devarakonda, Daniel Morgensztern, Ramaswamy Govindan
Oncology (Williston Park, N.Y.)|November 29, 2013
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinomaSiddhartha Devarakonda, Daniel Morgensztern, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
MET Mutation Associated with Responsiveness to CrizotinibSaiama N Waqar, Daniel Morgensztern, Jennifer Sehn
Journal of Thoracic Disease|September 14, 2016
Role for adjuvant chemotherapy in patients with resected small cell lung cancerLingling Du, Saiama N Waqar, Daniel Morgensztern
Hematology/Oncology Clinics of North America|December 4, 2016
Immunotherapy in Lung CancerLingling Du, Roy S Herbst, Daniel Morgensztern
Annals of Translational Medicine|November 22, 2016
Immune checkpoint inhibition in patients with brain metastasesTanner Johanns, Saiama N Waqar, Daniel Morgensztern
Cancer Treatment and Research|August 19, 2016
Multimodality Therapy for NSCLCLingling Du, Saiama N Waqar, Daniel Morgensztern
Pageof 19